NME1P1

Across TCGA pan-cancer cohorts, NME1P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of NME1P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where NME1P1 RNA is repressed in tumor relative to normal tissue. In most cancer types NME1P1 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

KIRC and LUAD are the cancer types where NME1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NME1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.015	.023	2	view →
LUAD	Male	All	+0.130	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

NME1P1–KIRC

Open the KIRC breakdown →